Literature DB >> 3349649

An idiotope-specific autoantibody in SLE.

C G Mackworth-Young1, R S Schwartz.   

Abstract

The public idiotype Id-16/6 and the public idiotope Id-LLa were originally defined on the same human monoclonal anti-DNA antibody, but they are also known to occur separately on other anti-DNA antibodies. We sought the presence of these immunoglobulin variable region markers in purified immunoglobulins from the serum of nine patients with systemic lupus erythematosus (SLE) and 33 healthy donors. Sera from five patients were positive for Id-16/6, and five were positive for Id-LLa. The immunoglobulin preparations were passed over a Sepharose-Id-16/6 column in order to recover auto-anti-idiotypes. An eluate of that column was obtained from the immunoglobulin preparation of one patient whose serum was Id-16/6+ and Id-LLa-. This eluate was shown by competition assay to bind to IdLLa. This is the first demonstration of spontaneously arising human auto-anti-idiotypes against a specific idiotypic system in SLE. The results suggest that antibodies against the Id-LLa idiotope may play a role in immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349649      PMCID: PMC1541646     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.

Authors:  R S Geha
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

2.  Characterization of anti-F(ab')2 antibodies in SLE patients. Evidence for cross-reacting auto-anti-idiotypic antibodies.

Authors:  H Nasu; D S Chia; O Taniguchi; E V Barnett
Journal:  Clin Immunol Immunopathol       Date:  1982-10

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

6.  Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy.

Authors:  N Suciu-Foca; E Reed; C Rohowsky; P Kung; D W King
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

7.  Expression of anti-idiotypic clones against auto-anti-DNA antibodies in normal individuals.

Authors:  M Zouali; A Eyquem
Journal:  Cell Immunol       Date:  1983-02-15       Impact factor: 4.868

8.  Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.

Authors:  D Geltner; E C Franklin; B Frangione
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

9.  Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation.

Authors:  M Goldman; L M Rose; A Hochmann; P H Lambert
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Naturally occurring autologous anti-idiotypic antibodies. Participation in immune complex formation in selective IgA deficiency.

Authors:  C Cunningham-Rundles
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  2 in total

1.  Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.

Authors:  R J Specht Grijp-Glandorf; E De Heer; C C Dekker-Nooren; M R Daha; L A Van Es
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  Distribution of anti-F(ab')2 antibodies and the 16/6 idiotype in systemic lupus erythematosus (SLE) probands and kindreds.

Authors:  F Silvestris; R A Searles; R C Williams; M A Rodriguez; R S Schwartz
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.